These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11400663)

  • 1. [HIV integrase inhibitors: a promising development in AIDS research].
    Zlotos DP
    Pharm Unserer Zeit; 2001; 30(3):186. PubMed ID: 11400663
    [No Abstract]   [Full Text] [Related]  

  • 2. The integrase of the human immunodeficiency virus as a novel target for the antiviral therapy of AIDS.
    Witvrouw M; Debyser Z
    Verh K Acad Geneeskd Belg; 2003; 65(5):325-34. PubMed ID: 14671848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V; Chi G
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
    Pace P; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of integrase inhibitors for treatment of AIDS: an overview.
    Dubey S; Satyanarayana YD; Lavania H
    Eur J Med Chem; 2007 Sep; 42(9):1159-68. PubMed ID: 17367896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV integrase: a target for AIDS therapeutics.
    Thomas M; Brady L
    Trends Biotechnol; 1997 May; 15(5):167-72. PubMed ID: 9161051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of dual inhibitors of HIV reverse transcriptase and integrase: introducing a diketoacid functionality into delavirdine.
    Wang Z; Vince R
    Bioorg Med Chem; 2008 Apr; 16(7):3587-95. PubMed ID: 18314335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cure for AIDS?
    Laurence J
    AIDS Read; 2007 Jul; 17(7):338-9. PubMed ID: 17672011
    [No Abstract]   [Full Text] [Related]  

  • 9. Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
    Wai JS; Kim B; Fisher TE; Zhuang L; Embrey MW; Williams PD; Staas DD; Culberson C; Lyle TA; Vacca JP; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Mallai R; Young SD
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5595-9. PubMed ID: 17822898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
    Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
    J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
    Dessalew N
    Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrase inhibitors and cellular immunity suppress retroviral replication in rhesus macaques.
    Hazuda DJ; Young SD; Guare JP; Anthony NJ; Gomez RP; Wai JS; Vacca JP; Handt L; Motzel SL; Klein HJ; Dornadula G; Danovich RM; Witmer MV; Wilson KA; Tussey L; Schleif WA; Gabryelski LS; Jin L; Miller MD; Casimiro DR; Emini EA; Shiver JW
    Science; 2004 Jul; 305(5683):528-32. PubMed ID: 15247437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Neamati N
    ChemMedChem; 2006 Feb; 1(2):238-44. PubMed ID: 16892356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones.
    Boros EE; Johns BA; Garvey EP; Koble CS; Miller WH
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5668-72. PubMed ID: 16908139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrase inhibitors.
    García-Gasco P; Blanco F; Soriano V
    J HIV Ther; 2005 Dec; 10(4):75-8. PubMed ID: 16519247
    [No Abstract]   [Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of heteroaryl diketohexenoic and diketobutanoic acids as HIV-1 integrase inhibitors endowed with antiretroviral activity.
    Di Santo R; Costi R; Artico M; Ragno R; Greco G; Novellino E; Marchand C; Pommier Y
    Farmaco; 2005 May; 60(5):409-17. PubMed ID: 15910813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as advanced inhibitors of HIV integrase.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2007 Aug; 15(16):5487-92. PubMed ID: 17560110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.
    Summa V; Petrocchi A; Bonelli F; Crescenzi B; Donghi M; Ferrara M; Fiore F; Gardelli C; Gonzalez Paz O; Hazuda DJ; Jones P; Kinzel O; Laufer R; Monteagudo E; Muraglia E; Nizi E; Orvieto F; Pace P; Pescatore G; Scarpelli R; Stillmock K; Witmer MV; Rowley M
    J Med Chem; 2008 Sep; 51(18):5843-55. PubMed ID: 18763751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant substances as anti-HIV agents selected according to their putative mechanism of action.
    Cos P; Maes L; Vanden Berghe D; Hermans N; Pieters L; Vlietinck A
    J Nat Prod; 2004 Feb; 67(2):284-93. PubMed ID: 14987070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.